Vor Biopharma (VOR) Share-based Compensation (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Share-based Compensation of $8.9 million for Q1 2026, up 358.87% year-over-year from $1.9 million in Q1 2025, and down 43.98% quarter-over-quarter from $15.8 million in Q4 2025.
Vor Biopharma (VOR) Share-based Compensation (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Share-based Compensation for 7 consecutive years, with $8.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 358.87% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $34.6 million (up 297.47% YoY), while the FY2025 annual figure was $113.4 million, up 1051.62% from the prior year.
- Share-based Compensation declined to $8.9 million in Q1 2026 per VOR's latest filing, from $15.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $16.6 million in Q4 2022 and bottomed at -$10.3 million in Q4 2023.
- Historically, Share-based Compensation has averaged $3.8 million across 5 years, with a median of $2.3 million in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 1276.56% — and 2023, when it slumped 162.08%.
- Vor Biopharma's Share-based Compensation stood at $16.6 million in 2022, then plunged by 162.08% to -$10.3 million in 2023, then jumped by 116.62% to $1.7 million in 2024, then soared by 826.45% to $15.8 million in 2025, then sank by 43.98% to $8.9 million in 2026.
- Business Quant data shows VOR's Share-based Compensation at $8.9 million in Q1 2026, $15.8 million in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 107.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 107.30 Mn |
| Jun 30, 2026 | 107.30 Mn |
| Mar 31, 2026 | 8.87 Mn |
| Mar 31, 2026 | 8.87 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Sep 30, 2025 | 8.03 Mn |
| Sep 30, 2025 | 8.03 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.71 Mn |
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 182,000.00 |
| Mar 31, 2024 | 182,000.00 |